Exact Sciences (EXAS) Tops Q1 EPS by 1c, Company Pleased with Launch Trajectory of Cologuard

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/12/2026

1. MIRM
2. SPY
3. META
4. MSFT
5. PLTR
6. JNJ
7. HUM
8. CSCO
9. KTOS
10. NVDA

Go back to Exact Sciences (EXAS) Tops Q1 EPS by 1c, Company Pleased with Launch Trajectory of Cologuard

Exact Sciences Reports Strong Growth Trajectory for Cologuard™ in First-Quarter 2015

May 4, 2015 5:00 AM EDT

MADISON, Wis.--(BUSINESS WIRE)-- Exact Sciences Corp. (Nasdaq: EXAS) today announced its business and financial results for the quarter ending March 31, 2015, reporting that 11,000 Cologuard tests were completed and that the number of ordering physicians more than doubled, increasing from 4,100 at the end of 2014 to 8,300 in the first quarter of 2015.

We are pleased with the strong launch trajectory of Cologuard, said Kevin Conroy, Exact Sciences chairman and CEO. Demand among patients and physicians and acceptance among commercial insurers is accelerating.

The company expanded its team of sales professionals from 80 to 140 during... More